CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
In conclusion, there is insufficient evidence to warrant systematic thyroid screening in CHEK2 carriers.
Source: Hereditary Cancer in Clinical Practice - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Colorectal Cancer | Thyroid | Thyroid Cancer